Biosig Technologies Profit Margin

The latest profit margin for BSGM is -343038.36% as of June 2026. That compares with -186792.31% in the prior-year period — down 83.6% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Biosig Technologies's historical trend and sector peers before judging valuation or financial health.

Over the past year, BSGM's profit margin moved from -186792.31% to -343038.36% — a 83.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biosig Technologies's valuation or profitability profile.

Against Healthcare companies, BSGM currently prints -343038.36% for profit margin, while the sector average sits near 21.34%. That is roughly 1607951.2% below the sector mean. Large gaps often invite a closer look at Biosig Technologies's growth, margins, and balance sheet.

Profit Margin shows how effectively Biosig Technologies converts resources into returns. At -343038.36%, BSGM may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -186792.31% in the prior-year period — down 83.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BSGM's profit margin (-343038.36%), review year-over-year change from -186792.31%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.